keep an eye on...?, page-145

Announce just out on neu

The Fragile X Drug Validation Initiative (FX-DVI), an independent research institute supported by the Fragile X Alliance (FRAXA), has completed a study using NNZ-2591 in a mouse model of Fragile X Syndrome (fmr1 knockout mouse model). This experiment replicated the study with Neuren's lead drug molecule, NNZ-2566, the results of which were announced in November 2012.

Neu are still on mouse experiments with both their compounds,,,,!!!!

ANP 's. pipeline has been tried on humans with great ,promising results...go figure...that's why PATTO's refrained from putting a value on their research paper on ANP

Safe to say it well & truly exceeds neu?.imo